|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM314406212 |
003 |
DE-627 |
005 |
20231225152647.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2020 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.2144/btn-2020-0046
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1047.xml
|
035 |
|
|
|a (DE-627)NLM314406212
|
035 |
|
|
|a (NLM)32867513
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Hira, Vashendriya Vv
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a 2D and 3D in vitro assays to quantify the invasive behavior of glioblastoma stem cells in response to SDF-1α
|
264 |
|
1 |
|c 2020
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 07.10.2021
|
500 |
|
|
|a Date Revised 07.10.2021
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Invasion is a hallmark of cancer and therefore in vitro invasion assays are important tools in cancer research. We aimed to describe in vitro 2D transwell assays and 3D spheroid assays to quantitatively determine the invasive behavior of glioblastoma stem cells in response to the chemoattractant SDF-1α. Matrigel was used as a matrix in both assays. We demonstrated quantitatively that SDF-1α increased invasive behavior of glioblastoma stem cells in both assays. We conclude that the 2D transwell invasion assay is easy to perform, fast and less complex whereas the more time-consuming 3D spheroid invasion assay is physiologically closer to the in vivo situation
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a 2D transwell invasion assay
|
650 |
|
4 |
|a 3D spheroid invasion assay
|
650 |
|
4 |
|a cancer cell
|
650 |
|
4 |
|a cellular invasion
|
650 |
|
4 |
|a glioblastoma stem cells
|
650 |
|
7 |
|a CXCR4 protein, human
|2 NLM
|
650 |
|
7 |
|a Chemokine CXCL12
|2 NLM
|
650 |
|
7 |
|a Drug Combinations
|2 NLM
|
650 |
|
7 |
|a Laminin
|2 NLM
|
650 |
|
7 |
|a Proteoglycans
|2 NLM
|
650 |
|
7 |
|a Receptors, CXCR4
|2 NLM
|
650 |
|
7 |
|a matrigel
|2 NLM
|
650 |
|
7 |
|a 119978-18-6
|2 NLM
|
650 |
|
7 |
|a Collagen
|2 NLM
|
650 |
|
7 |
|a 9007-34-5
|2 NLM
|
700 |
1 |
|
|a Breznik, Barbara
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Van Noorden, Cornelis Jf
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lah, Tamara
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Molenaar, Remco J
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t BioTechniques
|d 1988
|g 69(2020), 5 vom: 03. Nov., Seite 339-346
|w (DE-627)NLM012627046
|x 1940-9818
|7 nnns
|
773 |
1 |
8 |
|g volume:69
|g year:2020
|g number:5
|g day:03
|g month:11
|g pages:339-346
|
856 |
4 |
0 |
|u http://dx.doi.org/10.2144/btn-2020-0046
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_21
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_50
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_99
|
912 |
|
|
|a GBV_ILN_121
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_618
|
912 |
|
|
|a GBV_ILN_640
|
912 |
|
|
|a GBV_ILN_754
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2002
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2007
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2009
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2012
|
912 |
|
|
|a GBV_ILN_2015
|
912 |
|
|
|a GBV_ILN_2018
|
912 |
|
|
|a GBV_ILN_2023
|
912 |
|
|
|a GBV_ILN_2035
|
912 |
|
|
|a GBV_ILN_2040
|
912 |
|
|
|a GBV_ILN_2060
|
912 |
|
|
|a GBV_ILN_2099
|
912 |
|
|
|a GBV_ILN_2105
|
912 |
|
|
|a GBV_ILN_2121
|
912 |
|
|
|a GBV_ILN_2470
|
951 |
|
|
|a AR
|
952 |
|
|
|d 69
|j 2020
|e 5
|b 03
|c 11
|h 339-346
|